Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation

Hepatogastroenterology. 1994 Oct;41(5):424-6.

Abstract

Hepatitis B virus-DNA was detected by polymerase chain reaction in 9 out of 10 patients after orthotopic liver transplantation. Three of these patients were at the same time positive for hepatitis B virus-DNA by dot-blot hybridization (hepatitis B virus-DNA > 1.5 pg/ml). In these three patients HBs-antigen (HBsAg) reappeared within a mean time of 12 weeks after orthotopic liver transplantation (range 7-18 weeks). Only two of the six polymerase chain reaction-positive and dot-blot-negative patients (hepatitis B virus-DNA between 0.4 fg/ml and 1.5 pg/ml) had recurrence of HBsAg within a mean time of 54 weeks (range 52-56 weeks). Passive immunoprophylaxis with anti-HBs antibodies (serum titers > 100 IU/l) did not prevent infection of the graft in the five reinfected patients. We conclude that a low concentration of serum hepatitis B virus-DNA after orthotopic liver transplantation, which is detectable only by polymerase chain reaction, indicates a delayed infection of the graft.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Biomarkers / blood
  • DNA, Viral / analysis*
  • Female
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Hepatitis B virus / isolation & purification*
  • Humans
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / surgery*
  • Liver Cirrhosis / virology*
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Postoperative Care
  • Prognosis
  • Recurrence
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens